Q1: 2026-04-30 Earnings Summary
EPS of $1.58 beats by $0.16
|
Revenue of
$11.49B
(2.57% Y/Y)
beats by $571.70M
Bristol-Myers Squibb Company (BMY) Q1 2026 Earnings Call April 30, 2026 8:00 AM EDT
Company Participants
Charles Triano - SVP & Head of Investor Relations
Christopher Boerner - CEO & Chairman
David Elkins - Executive VP & CFO
Cristian Massacesi - Executive VP, Chief Medical Officer & Head of Development
Adam Lenkowsky - Executive VP & Chief Commercialization Officer
Conference Call Participants
Asad Haider - Goldman Sachs Group, Inc., Research Division
Geoffrey Meacham - Citigroup Inc., Research Division
Alexandria Hammond - Wolfe Research, LLC
Christopher Schott - JPMorgan Chase & Co, Research Division
Evan Seigerman - BMO Capital Markets Equity Research
Michael Yee - UBS Investment Bank, Research Division
Akash Tewari - Jefferies LLC, Research Division
Louise Chen - Scotiabank Global Banking and Markets, Research Division
Terence Flynn - Morgan Stanley, Research Division
Seamus Fernandez - Guggenheim Securities, LLC, Research Division
Mohit Bansal - Wells Fargo Securities, LLC, Research Division
Presentation
Operator
Welcome to the Bristol-Myers Squibb First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Chuck Triano, Senior Vice President and Head of Investor Relations. Please go ahead.
Charles Triano
SVP & Head of Investor Relations
Thank you, and good morning, everyone. We appreciate you joining our first quarter 2026 earnings call. With me this morning with prepared remarks are Chris Boerner, our Board Chair and Chief Executive Officer; and David Elkins, our Chief Financial Officer. Also participating in today's call is Adam Lenkowsky, our Chief Commercialization Officer; and Cristian Massacesi, our Chief Medical Officer and Head of Global Drug Development. Earlier this morning, we posted our quarterly slide presentation to bms.com that you can use to follow along with Chris and David's remarks.
Before we get started, I'll remind everybody that during this call, we will make statements about the company's future plans and prospects that
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。